RxDoctor Payments Data

Joseph Moran, DPM

Foot Surgery · Columbia, SCNPI 1952360083

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $968 of the $1,324 with a category attached, or 73.1%. It is spread thinly across 14 manufacturers, the largest accounting for just 15.5%. Reporting peaked in 2024 at $544 and has fallen 75.0% since, to $136 in 2025.

$1,324in general payments, 2019–2025

Across 30 payments — averaging $44.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$205
  • Organogenesis Inc.$175
  • Stryker$174
  • Peerless Surgical Inc.$168
  • Convatec Inc.$109
  • Smith+Nephew$109
  • plus $385 from 8 others

What the payments were for

  • Consulting fees$1008%
  • Travel & lodging$16112%
  • Food & beverage$96873%
  • Gifts$957%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex4$205
Organogenesis Inc.1$175
Stryker(2 entities)4$174
Peerless Surgical Inc.3$168
Convatec Inc.2$109
Smith+Nephew1$109
Comsort, Inc1$100
Crossroads Extremity Systems, LLC1$83
Sebela Pharmaceuticals Inc.5$77
Johnson & Johnson2$68
Amgen2$24
Trice Medical, Inc.1$15
Prugen, Inc. Pharmaceuticals2$11
Glenmark Therapeutics Inc.1$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,324 in reported general payments places this provider in the 60th percentile of 28 foot surgery providers in South Carolina.

See all foot surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$168,635
Medicare patients
644
Services billed
1,955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin179$2,107
Ammonium Lactate81$1,654
Ketoconazole30$842
Mupirocin69$491
Terbinafine Hcl33$483
Ciclopirox17$425
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$351
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$307
Cephalexin25$191
Doxycycline Hyclate17$127
Colchicine13$123
Meloxicam53$87
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$69

Paid to pharmacies, not to this prescriber.

Other foot surgery in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →